SCHEMBL5193643

SCHEMBL5193643

CC(CCc1ccccc1)NC(=O)CC1CCCCN1

nearest known ligand 0.60

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.54
HTT P42858 3/20 0.54
POLB P06746 3/20 0.51
KMT2A Q03164 4/20 0.50
MEN1 O00255 3/20 0.50
SMN1; SMN2 Q16637 3/20 0.50
HPGD P15428 1/20 0.50
ESR1 P03372 1/20 0.49
ESR2 Q92731 1/20 0.49
RECQL P46063 1/20 0.48
MAPT P10636 1/20 0.48
NPSR1 Q6W5P4 1/20 0.47
NPC1 O15118 1/20 0.47
RAB9A P51151 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5192295 0.78 CCR2 (0.41) ALDH1A1KMT2AMEN1
SCHEMBL8120752 0.77 GHSR (0.45) ALDH1A1HPGDMAPT
SCHEMBL6297588 0.76 ALDH1A1 (0.81) ALDH1A1HTTPOLBKMT2AMEN1
SCHEMBL7259516 0.74 EPHX2 (0.61) POLBKMT2ASMN1; SMN2HPGDNPC1
SCHEMBL2029199 0.74 EPHX2 (0.61) POLBKMT2ASMN1; SMN2HPGDNPC1
SCHEMBL5193935 0.73 L3MBTL1 (0.41) ALDH1A1HTTPOLBHPGDNPC1
SCHEMBL25079322 0.73 CHRM5 (0.41) ALDH1A1HTTKMT2AMEN1SMN1; SMN2
SCHEMBL20456249 0.72 SMN1; SMN2 (0.65) ALDH1A1HTTPOLBKMT2AMEN1
SCHEMBL466055 0.72 POLB (0.51) POLBKMT2ANPC1RAB9A
SCHEMBL5192074 0.71 KMT2A (0.49) ALDH1A1HTTKMT2AMEN1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0968206-B8 N-HETEROCYCLIC DERIVATIVES AS NOS INHIBITORS BERLEX INC (US) 2007-01-24 EP disclosed
EP-0968206-A1 N-HETEROCYCLIC DERIVATIVES AS NOS INHIBITORS BERLEX LABORATORIES, INC. (US) 2000-01-05 EP disclosed
WO-1998037079-A1 N-HETEROCYCLIC DERIVATIVES AS NOS INHIBITORS BERLEX LABORATORIES, INC. (US) 1998-08-27 WO disclosed